Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis.

Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis. Future Oncol. 2021 Aug; 17(23):3027-3035.

View in: PubMed

subject areas

Administration, Oral
Adult
Antiemetics
Antineoplastic Agents
Cisplatin
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Drug Administration Schedule
Drug Combinations
Female
Humans
Isoquinolines
Male
Middle Aged
Multicenter Studies as Topic
Nausea
Neoplasms
Pyridines
Quinuclidines
Randomized Controlled Trials as Topic
Vomiting

authors with profiles

Rudolph Navari